Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

India · Delayed Price · Currency is INR

109.48

-1.67 (-1.50%)

At close: Oct 1, 2026

Market Cap	7.97B
Revenue (ttm)	1.06B +49.8%
Net Income	231.61M +20.8%
EPS	3.57 +14.5%
Shares Out	72.79M
PE Ratio	30.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	248,603
Open	109.00
Previous Close	111.15
Day's Range	105.20 - 112.61
52-Week Range	69.18 - 163.18
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; egg freezing; embryo freezing; frozen embryo transfer; gynae co... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 2009

Employees 120

Stock Exchange National Stock Exchange of India

Ticker Symbol GAUDIUMIVF

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:GAUDIUMIVF's revenue was 1.04 billion, an increase of 47.56% compared to the previous year's 707.24 million. Earnings were 244.61 million, an increase of 27.58%.

Financial Statements